Related Causal Frameworks for Surrogate Outcomes

被引:144
作者
Joffe, Marshall M. [1 ]
Greene, Tom [2 ]
机构
[1] Univ Penn, Sch Med, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA
[2] Univ Utah, Div Epidemiol, Salt Lake City, UT 84112 USA
关键词
Causal inference; Randomized trial; Surrogate outcome; CLINICAL-TRIALS; END-POINTS; MODELS; INFERENCE; EPIDEMIOLOGY; EXPOSURE;
D O I
10.1111/j.1541-0420.2008.01106.x
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Four major frameworks have been developed for evaluating surrogate markers in randomized trials: one based on conditional independence of observable variables, another based on direct and indirect effects, a third based on a meta-analysis, and a fourth based on principal stratification. The first two of these fit into a paradigm we call the causal-effects (CE) paradigm, in which, for a good surrogate, the effect of treatment on the surrogate, combined with the effect of the surrogate on the clinical outcome, allow prediction of the effect of the treatment on the clinical outcome. The last two approaches fall into the causal-association (CA) paradigm, in which the effect of the treatment on the surrogate is associated with its effect on the clinical outcome. We consider the CE paradigm first, and consider identifying assumptions and some simple estimation procedures; we then consider the CA paradigm. We examine the relationships among these approaches and associated estimators. We perform a small simulation study to illustrate properties of the various estimators under different scenarios, and conclude with a discussion of the applicability of both paradigms.
引用
收藏
页码:530 / 538
页数:9
相关论文
共 25 条
[1]   Mediation analysis via potential outcomes models [J].
Albert, Jeffrey M. .
STATISTICS IN MEDICINE, 2008, 27 (08) :1282-1304
[2]  
[Anonymous], 2006, The Evaluation of Surrogate Endpoints
[3]  
[Anonymous], J AM STAT ASSOC
[4]  
[Anonymous], 2001, P 17 C UNC ART INT S
[5]   THE MODERATOR MEDIATOR VARIABLE DISTINCTION IN SOCIAL PSYCHOLOGICAL-RESEARCH - CONCEPTUAL, STRATEGIC, AND STATISTICAL CONSIDERATIONS [J].
BARON, RM ;
KENNY, DA .
JOURNAL OF PERSONALITY AND SOCIAL PSYCHOLOGY, 1986, 51 (06) :1173-1182
[6]  
Daniels MJ, 1997, STAT MED, V16, P1965, DOI 10.1002/(SICI)1097-0258(19970915)16:17<1965::AID-SIM630>3.0.CO
[7]  
2-M
[8]   Modelling treatment-effect heterogeneity in randomized controlled trials of complex interventions (psychological treatments) [J].
Dunn, Graham ;
Bentall, Richard .
STATISTICS IN MEDICINE, 2007, 26 (26) :4719-4745
[9]   Surrogate end points in clinical trials: Are we being misled? [J].
Fleming, TR ;
DeMets, DL .
ANNALS OF INTERNAL MEDICINE, 1996, 125 (07) :605-613
[10]   Principal stratification in causal inference [J].
Frangakis, CE ;
Rubin, DB .
BIOMETRICS, 2002, 58 (01) :21-29